COVID-19 vaccination in cancer patients: a narrative review

SL Seneviratne, P Yasawardene… - Journal of …, 2022 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has affected over 220 million individuals worldwide, and has …

Cancer patients and the COVID-19 vaccines: considerations and challenges

M Almasri, K Bshesh, W Khan, M Mushannen… - Cancers, 2022 - mdpi.com
Simple Summary Coronavirus disease 2019 (COVID-19) is the greatest present-day public
and global health challenge, and patients with cancer are especially vulnerable …

COVID-19 vaccination in cancer patients: A review article

R Mekkawi, BA Elkattan, A Shablak, M Bakr… - Cancer …, 2022 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19) infection is caused by severe acute respiratory
syndrome coronavirus 2. Adults with cancer are immunocompromised due to several causes …

[HTML][HTML] COVID-19 vaccination for cancer patients: evidence, priority, and practice

S Rajan, N Akhtar, S Sharma, D Chakrabarti, V Kumar - Vaccine, 2021 - ncbi.nlm.nih.gov
Practising universal precautions and getting vaccinated are the only preventive strategies
during this COVID-19 pandemic. The universal precautions have been there in all …

COVID-19 vaccines in cancer patients. Seropositivity and safety. Systematic review and meta-analysis

L Cavanna, C Citterio, I Toscani - Vaccines, 2021 - mdpi.com
Patients with cancer are among the most vulnerable groups of the COVID-19 pandemic,
whereas vaccinations can represent a cornerstone in overcoming the pandemic itself …

Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis

A Sakuraba, A Luna, D Micic - Journal of hematology & oncology, 2022 - Springer
Purpose Patients with cancer have an increased risk of coronavirus disease 2019 (COVID-
19) and an attenuated responses to various vaccines. This meta-analysis aims to assess the …

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety

A Fendler, EGE de Vries… - Nature Reviews …, 2022 - nature.com
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …

[HTML][HTML] Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art

N Ivanov, B Krastev, DG Miteva… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Although the coronavirus disease 2019 (COVID-19) pandemic was declared to be no longer
“a public health emergency of international concern” with its wide range of clinical …

Cancer or COVID-19? A review of recommendations for COVID-19 vaccination in cancer patients

MK Gundavda, KK Gundavda - Current Treatment Options in Oncology, 2021 - Springer
Opinion statement While emergency use is authorized for numerous COVID-19 vaccines
and the high-risk population including cancer patients or those with immunosuppression …

Vaccination of cancer patients against COVID-19: towards the end of a dilemma

A Mandal, P Singh, A Samaddar, D Singh, M Verma… - Medical Oncology, 2021 - Springer
With the emergence of second wave of COVID-19 infection globally, particularly in India in
March–April 2021, protection by massive vaccination drive has become the need of the …